TRISTEL plc
("Tristel" or the "Company")
Conference attendance at Mello2025 Investor event
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Tristel will be presenting and exhibiting at the Mello2025 investor event on Tuesday 3 June 2025, which will be held at The Clayton Hotel & Conference Centre, Chiswick High Road, London, W4 5RY.
Matt Sassone, CEO of Tristel plc, will be presenting at 10:10am (BST) and 14:05pm (BST) on the day providing an overview of the Company and strategy. No new information will be disclosed at the event and a PDF of the presentation will be made available on the Company's website at https://investors.tristel.com/investor-hub/
For further information and tickets for the Mello2025 conference, please visit the event website at www.melloevents.com/mello2025.
For further information please contact:
| Tristel plc | Via Walbrook PR | ||
| Matt Sassone, Chief Executive Officer | |||
| Liz Dixon, Chief Financial Officer | | ||
| | | ||
| Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | ||
| Paul McManus / Lianne Applegarth / Alice Woodings | Mob: 07980 541 893/ 07584 391 303/ 07407 804 654 | ||
| | | ||
| Cavendish Capital Markets Ltd | Tel: 020 7220 0500 | ||
| Geoff Nash / Trisyia Jamaludin (Corporate Finance) | | ||
| Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) | | ||
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets annual revenue growth of between 10% and 15% and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.